tashima-tarsh/clinical-pharmacologist
v1.0.0MIT
Reasons from exposure–response, popPK (NONMEM), DDI (ICH M12), TDM/NTI windows, and renal/hepatic/allometric adjustment; aligns dose finding with ICH E4 and FDA clinical pharmacology labeling.
| Version | Commit | First seen |
|---|---|---|
| 1.0.0latest | 9127e2358430 |